We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+8.61%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.42B
AUM Growth
-$3.38B
Cap. Flow
-$3.75B
Cap. Flow %
-69.25%
Top 10 Hldgs %
40.63%
Holding
1,042
New
84
Increased
109
Reduced
414
Closed
284
Avg Time Held Equity + Options
3.7 quarters
Top 10 Avg Time Held Equity + Options
0.5 quarters
Top 20 Avg Time Held Equity + Options
0.8 quarters
Avg Time Held Equity only
3.7 quarters
Top 10 Avg Time Held Equity only
0.5 quarters
Top 20 Avg Time Held Equity only
0.8 quarters

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$184M
2
STOR
STORE Capital Corporation
STOR
+$172M
3
FHN icon
First Horizon
FHN
+$107M
4
COUP
Coupa Software Incorporated
COUP
+$96.9M
5
AAWW
Atlas Air Worldwide Holdings, Inc.
AAWW
+$64.6M

Top Sells

Rank Stock Value
1
BHVN icon
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$572M
2
ZEN
ZENDESK INC
ZEN
+$456M
3
AVLR
Avalara, Inc.
AVLR
+$373M
4
SWCH
Switch, Inc. Class A Common Stock
SWCH
+$271M
5
ROG icon
Rogers Corp
ROG
+$219M

Sector Composition

Rank Sector Weight
1 Financials 25.7%
2 Technology 18.31%
3 Healthcare 15.11%
4 Miscellaneous 11.75%
5 Real Estate 10.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
HERA
151
DELISTED
FTAC Hera Acquisition Corp. Class A Ordinary Shares
HERA
$4.77M 0.09%
471,086
-4,610
-1% -$46.1K
2021 Q2
6 quarters
BIOS
152
DELISTED
BioPlus Acquisition Corp. Class A Ordinary Shares
BIOS
$4.76M 0.09%
463,372
-4,535
-1% -$46K
2022 Q1
3 quarters
POW icon
153
DELISTED
Powered Brands Class A Ordinary Shares
POW
$4.76M 0.09%
470,613
-4,625
-1% -$46.4K
2021 Q2
6 quarters
LDHA
154
DELISTED
LDH Growth Corp I Class A Ordinary Shares
LDHA
$4.76M 0.09%
472,245
-4,621
-1% -$46.2K
2021 Q2
6 quarters
LVRA
155
DELISTED
Levere Holdings Corp. Class A Ordinary Shares
LVRA
$4.76M 0.09%
471,331
-4,612
-1% -$46K
2021 Q2
6 quarters
ACQR
156
DELISTED
Independence Holdings Corp. Class A Ordinary Share
ACQR
$4.75M 0.09%
471,086
-4,610
-1% -$46.1K
2021 Q2
6 quarters
AGGR
157
DELISTED
Agile Growth Corp
AGGR
$4.75M 0.09%
471,086
-4,610
-1% -$46.1K
2021 Q2
6 quarters
WPCB
158
DELISTED
Warburg Pincus Capital Corporation I-B
WPCB
$4.75M 0.09%
471,086
-4,610
-1% -$46.1K
2021 Q2
6 quarters
ESM
159
DELISTED
ESM Acquisition Corporation
ESM
$4.75M 0.09%
471,086
-4,610
-1% -$46.1K
2021 Q2
6 quarters
TZPS
160
DELISTED
TZP Strategies Acquisition Corp. Class A Ordinary Share
TZPS
$4.75M 0.09%
470,613
-4,625
-1% -$46.3K
2021 Q1
7 quarters
FCAX
161
DELISTED
Fortress Capital Acquisition Corp.
FCAX
$4.75M 0.09%
470,613
-4,625
-1% -$46.4K
2021 Q1
7 quarters
BNAI icon
162
Brand Engagement Network
BNAI
$39.6M
$4.75M 0.09%
47,109
-461
-1% -$46K
2021 Q2
6 quarters
THCP icon
163
DELISTED
Thunder Bridge Capital Partners IV, Inc. Class A Common Stock
THCP
$4.75M 0.09%
472,993
-4,629
-1% -$45.4K
2021 Q3
5 quarters
BLUA icon
164
DELISTED
BlueRiver Acquisition Corp.
BLUA
$4.75M 0.09%
470,613
-4,625
-1% -$46.2K
2021 Q1
7 quarters
PNTM
165
DELISTED
Pontem Corporation
PNTM
$4.75M 0.09%
469,498
-4,614
-1% -$46.3K
2021 Q1
7 quarters
CLAA
166
DELISTED
Colonnade Acquisition Corp. II
CLAA
$4.74M 0.09%
471,086
-4,610
-1% -$46K
2021 Q2
6 quarters
LHC
167
DELISTED
Leo Holdings Corp. II
LHC
$4.74M 0.09%
470,053
-4,620
-1% -$46.3K
2021 Q1
7 quarters
TWNI
168
DELISTED
Tailwind International Acquisition Corp.
TWNI
$4.74M 0.09%
470,077
-4,620
-1% -$46.2K
2021 Q2
6 quarters
SCAQ
169
DELISTED
Stratim Cloud Acquisition Corp. Class A Common Stock
SCAQ
$4.74M 0.09%
470,779
-4,607
-1% -$45.8K
2021 Q2
6 quarters
ZTAQU
170
DELISTED
Zimmer Energy Transition Acquisition Corp. Units
ZTAQU
$4.74M 0.09%
472,622
-4,624
-1% -$45.9K
2021 Q3
5 quarters
AEON icon
171
AEON Biopharma
AEON
$13.8M
$4.73M 0.09%
6,536
-65
-1% -$46.6K
2021 Q2
6 quarters
HCNE
172
DELISTED
Jaws Hurricane Acquisition Corp. Class A Common Stock
HCNE
$4.73M 0.09%
472,621
-4,625
-1% -$45.7K
2021 Q3
5 quarters
TETC
173
DELISTED
Tech and Energy Transition Corporation Class A Common Stock
TETC
$4.72M 0.09%
471,086
-4,610
-1% -$45.8K
2021 Q2
6 quarters
SOAR icon
174
Volato Group
SOAR
$16.6M
$4.72M 0.09%
18,535
-181
-1% -$45.4K
2022 Q1
3 quarters
LCAA
175
DELISTED
L Catterton Asia Acquisition Corp Class A Ordinary Shares
LCAA
$4.72M 0.09%
466,922
-4,569
-1% -$45.7K
2021 Q2
6 quarters
5 6
7
8 9

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q4 2022 Portfolio in Review

As of Q4 2022, UBS O'Connor held 1,042 positions worth $5.42B, down 38% from $8.8B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor withdrew a net $3.75B in Q4 2022, closing 284 positions and reducing 414 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Coupa Software Incorporated worth $128M.

  • UBS O'Connor's largest Q4 2022 buy was Coupa Software Incorporated: 1,619,333 shares worth $128M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
  • UBS O'Connor's biggest Q4 2022 reduction was Rogers Corp, cutting an estimated $219M.
  • UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
  • UBS O'Connor's ten largest holdings make up 41% of its $5.42B portfolio in Q4 2022.
  • UBS O'Connor opened 84 new positions and closed 284 in Q4 2022.
  • UBS O'Connor's portfolio value fell 38% quarter-over-quarter to $5.42B.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.